TrialCNS drugs2019

Safety, Pharmacokinetics and Pharmacodynamics of TNHH, a Novel Targeted Neutrophil-Inhibitory Hirulog Hybrid Glycoprotein, in Healthy Volunteers.

Zhong Ping Gou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.